Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

New Stock Coverage: Denture Maker Prestige Brands Holdings, Inc. Puts Its Money Where Its Mouth Is


Wall Street ratings agencies set the tone for today's stock market.

From a praiseworthy Priceline (PCLN) - up 3.91% for its ninth straight gain - to Nine West owner Jones Group (JNY), which jumped 7.58% to a fresh 52-week peak, Wall Street's fat cats clearly love their nine lives. (The imminent return of arch nemesis client number nine? Not so much.) As the S&P 500 (^GSPC) posted another impressive increase, Ford Motor (F), newly favored by the Pope, reached a new multi-year peak. The auto outfit should enjoy the acclaim while it lasts, for it never does. Meredith Whitney, who has gone from a free lunch to a public grilling in the space of 48-hours, can attest to that.

There are no top-tier economic reports released today. On the earnings front, expect quarterly announcements out of Helen of Troy (HELE), Hi-Tech Pharmacal (HITK), and Wolverine World Wide (WWW).

Atlas Resource Partners, L.P. (ARP): JPMorgan launches the limited partnership at a Neutral.

Autodesk, Inc. (ADSK): Boutique broker B. Riley has a new Neutral on the tech name.

Franklin Electric Co. (FELE): FELE is a fresh Outperform with Wedbush.

Oxford Industries, Inc. (OXM): Roth Capital resumes Buy-rated coverage on OXM, whose brands include Tommy Bahama.

Prestige Brands Holdings, Inc. (PBH): Shares are begun with a Buy at B. Riley & Co, whose price objective is $38 on an outfit it says has 70% of sales in 14 key labels that they believe are capable of 6% to 8% annual growth. Its brands include Efferdent dentures, Luden's cough drops, and Dramamine motion sickness products.

SolarCity Corp (SCTY): Maxim Group has a hold on the alternative energy outfit.

Technology Stocks: Piper Jaffray picks up Seagate Technology PLC (STX) at a Neutral and has a new Overweight on Western Digital Corp (WDC).

Verastem Inc (VSTM): Cantor Fitzgerald covers the company at a Buy and assigns it a $22 target price. Catalysts include the potentially imminent start of a Phase II trial to treat mesothelioma with VS-6063.

(See also: Stock Upgrades: Hewlett-Packard Company Continues Its Impressive Turnaround and Stock Downgrades: Run From the Robots of Intuitive Surgical, Inc.)
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Featured Videos